Early events following bovine leukaemia virus infection in calves with different alleles of the major histocompatibility complex DRB3 gene.

Cattle maintaining a low proviral load (LPL) status after bovine leukaemia virus (BLV) infection have been recognized as BLV controllers and non-transmitters to uninfected cattle in experimental and natural conditions. LPL has been associated with host genetics, mainly with the BoLA class II DRB3 gene. The aim of this work was to study the kinetics of BLV and the host response in Holstein calves carrying different BoLA-DRB3 alleles. Twenty BLV-free calves were inoculated with infected lymphocytes. Two calves were maintained uninfected as controls. Proviral load, total leukocyte and lymphocyte counts, anti-BLVgp51 titres and BLVp24 expression levels were determined in blood samples at various times post-inoculation. The viral load peaked at 30 days post-inoculation (dpi) in all animals. The viral load decreased steadily from seroconversion (38 dpi) to the end of the study (178 dpi) in calves carrying a resistance-associated allele (*0902), while it was maintained at elevated levels in calves with *1501 or neutral alleles after seroconversion. Leukocyte and lymphocyte counts and BLVp24 expression did not significantly differ between genetic groups. Animals with < 20 proviral copies/30 ng of DNA at 178 dpi or < 200 proviral copies at 88 dpi were classified as LPL, while calves with levels above these limits were considered to have high proviral load (HPL) profiles. All six calves with the *1501 allele progressed to HPL, while LPL was attained by 6/7 (86%) and 2/6 (33%) of the calves with the *0902 and neutral alleles, respectively. One calf with both *0902 and *1501 developed LPL. This is the first report of experimental induction of the LPL profile in cattle.

Characterization of a soy protein hydrolyzate for the development of a functional ingredient.

Argentina is a leading country in biodiesel production from soy. Extruded soy is a low-cost byproduct of the soybean oil industry, from which animal feeds are prepared as well as flour for human consumption. Soy proteins can be isolated from flours and digested with enzymes in order to obtain bioactive fractions. In this work, a commercial soy isolate (PRO-FAM 974) was characterized. Maximal solubility was achieved at a concentration of 90 mg/mL. Protein profiles obtained by SDS-PAGE showed that the isolate was constituted mostly by globulins. Conformational and thermal analyses (differential scanning calorimetry) showed that proteins were almost completely denatured. The isolate was hydrolyzed with a commercially available enzyme (COROLASE 7089). The peptide profile (MALDI-TOF) showed peptides ranging from 800 to 10,000 Daltons. We conclude that the product obtained has the potential to be used as functional ingredient for the development of functional foodstuffs, giving the opportunity to add value to the byproducts of the soybean oil industry.

Co-infection with Mycobacterium bovis does not alter the response to bovine leukemia virus in BoLA DRB3*0902, genetically resistant cattle.

High proviral load (HPL) profile in bovine leukemia virus infected animals poses increased risk of transmission, and development of HPL or low proviral load (LPL) profile may be attributed to host genetics. Genetic resistance and susceptibility has been mapped to the Major Histocompatibility Complex class II DRB3 gene (BoLA DRB3). The aim of this work was to determine the effect of Mycobacterium bovis infection on certain virological and host immunological parameters of BLV experimental infection. Twenty-six Argentinian Holstein calves carrying the resistance-associated marker allele BoLA DRB3*0902, susceptibility-associated marker allele BoLA DRB3*1501, or neutral BoLA DRB3 alleles, exposed to M. bovis were used. Twenty calves were inoculated with BLV, three were naturally infected and other three were BLV-negative. Seven from twenty six (27%) of the animals resulted positive to the PPD test. The proviral load, absolute leukocyte and lymphocyte counts, time to seroconversion, antibody titer against BLV, and viral antigen expression in vitro at various times post inoculation were determined and compared between PPD+ and PPD- animals. From a total of 23 BLV positive animals (naturally and experimentally infected), 13 (56.5%) developed HPL, and 10 (43.5%) developed LPL. None of the investigated parameters were affected by infection with M. bovis. We concluded that the ability of cattle carrying resistance-associated marker to control BLV and to progress towards a LPL phenotype was not altered by M. bovis co-infection.

Hot topic: Bovine leukemia virus (BLV)-infected cows with low proviral load are not a source of infection for BLV-free cattle.

The bovine leukemia virus (BLV) causes leukemia or lymphoma in cattle. Although most BLV-infected animals do not develop the disease, they maintain the transmission chain of BLV at the herd level. As a feasible approach to control the virus, selection of cattle carrying the BoLA-DRB3*0902 allele has been proposed, as this allele is strongly associated with a BLV infection profile or the low proviral load (LPL) phenotype. To test whether these cattle affect the BLV transmission chain under natural conditions, selected BLV-infected LPL-BoLA-DRB3*0902 heterozygous cows were incorporated into a BLV-negative dairy herd. An average ratio of 5.4 (range 4.17-6.37) BLV-negative cows per BLV-infected cow was maintained during the 20mo of the experiment, and no BLV-negative cattle became infected. The BLV incidence rate in this herd was thus zero, whereas BLV incidence rates in different local herds varied from 0.06 to 0.17 cases per 100 cattle-days. This finding strongly suggests that LPL-BoLA-DRB3*0902 cattle disrupted the BLV-transmission chain in the study period.

Leucosis bovina / Bovine leucosis

The enzootic form of bovine lymphosarcoma is the most common malignancy of cattle, especially dairy cattle. Its etiological agent, the bovine leukemia virus (BLV) is evolutionarily related to human T-cell leukemia viruses types I and II (HTLV and HTLV II). These three retroviruses share common structural and biological features that distingush them from other members of the retroviral family. BLV is widespread in the cattle population of most countries. However, clinical disease occurs much less frecuently and direct economic losses from morbidity and mortality are significant for individual cattle owners but not excessively burdensome to the cattle and meat packing industries. The primary economic loss to the cattle industry from bovine leukosis is tha actual and potential loss of export markets for cattle and semen. BLV can infect human and simian cells "in vitro", there is serological evidence that BLV infect chimpanzes and in the literature can be found circunstantial evidence for an association of bovine and human leukemia. There is hight incidence of BLV infectión in dairy cattle and the virus is excreted in milk. At present, no evidence had been found that BLV or infected cattle are human health hazards, however, any conclusion would be premature. To clarify this issue investigations applying the most sensitive methods will be necessary. Several sensitive and specific methods for the detection og BLV and BLV infected cattle have been developed. These include infectivity assays, serological tests, and molecular hydridization techniques. Since under natural conditions BLV is predominantly transmitted by contact and prenatural conditions BLV is predominantly transmitted by contact and prenatal infection occurs in less than 20% of calves born to infected dams, control and/or erradication programs wuld be feasibly

Leucosis bovina / Bovine leucosis

The enzootic form of bovine lymphosarcoma is the most common malignancy of cattle, especially dairy cattle. Its etiological agent, the bovine leukemia virus (BLV) is evolutionarily related to human T-cell leukemia viruses types I and II (HTLV and HTLV II). These three retroviruses share common structural and biological features that distingush them from other members of the retroviral family. BLV is widespread in the cattle population of most countries. However, clinical disease occurs much less frecuently and direct economic losses from morbidity and mortality are significant for individual cattle owners but not excessively burdensome to the cattle and meat packing industries. The primary economic loss to the cattle industry from bovine leukosis is tha actual and potential loss of export markets for cattle and semen. BLV can infect human and simian cells "in vitro", there is serological evidence that BLV infect chimpanzes and in the literature can be found circunstantial evidence for an association of bovine and human leukemia. There is hight incidence of BLV infectión in dairy cattle and the virus is excreted in milk. At present, no evidence had been found that BLV or infected cattle are human health hazards, however, any conclusion would be premature. To clarify this issue investigations applying the most sensitive methods will be necessary. Several sensitive and specific methods for the detection og BLV and BLV infected cattle have been developed. These include infectivity assays, serological tests, and molecular hydridization techniques. Since under natural conditions BLV is predominantly transmitted by contact and prenatural conditions BLV is predominantly transmitted by contact and prenatal infection occurs in less than 20% of calves born to infected dams, control and/or erradication programs wuld be feasibly (AU)